(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(naphthalen-2-yl)propanoic acid, 97%, 1g

(4-Methyl-quinolin-2-yl)-hydrazine, 95.0%, 2.5g

BITOPERTIN, 95%, 5mg

Sample vials with short thread ND9 Vial kit, HPLC-certified, Clear glass, with labelling space, 1 Set

4-Chloro-3-nitrobenzamide>98.0%(GC)5g

4-Amino-7-bromoquinoline, 95.0%, 100mg

7-Bromobenzo[d]oxazol-2(3H)-one, 95.0%, 250mg

(S)-(5-Azaspiro[2.4]heptan-6-yl)methanol hydrochloride, 95%, 250mg

3-Methyl-5-(trichloromethyl)-1,2,4-oxadiazole, 98+%, 1g

Ethyl 4-(3-chloro-4-fluorophenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate, 95%, 250mg

(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol, 95.0%, 100g

4-Bromo-2-fluoropyridine, 98.0%, 1g

3-(3-pyridinyl)-1H-pyrazole-5-carboxylic acid hydrochloride, 95.0%, 250mg